AMGEN INC (AMGN) Stock Analyst Ratings
USA - NASDAQ:AMGN - US0311621009 - Common Stock
319.86 USD
+23.16 (+7.81%)
319.12 USD
-0.74 (-0.23%)
ChartMill assigns a Buy % Consensus number of 72% to AMGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 319.63. This target is -0.07% below the current price.
AMGN was analyzed by 40 analysts. The buy percentage consensus is at 72. So analysts seem to be have mildly positive about AMGN.
In the previous month the buy percentage consensus was at a similar level.
AMGN was analyzed by 40 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-09-26 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-08-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-08-06 | UBS | Maintains | Neutral -> Neutral |
| 2025-08-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-08-06 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-23 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-07-22 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-07-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-27 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2025-06-24 | Cantor Fitzgerald | Reiterate | Neutral -> Neutral |
| 2025-05-16 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-07 | Mizuho | Maintains | Neutral -> Neutral |
| 2025-05-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-02 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-04-22 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-04-14 | UBS | Maintains | Neutral -> Neutral |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-03-05 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-02-10 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-02-06 | B of A Securities | Maintains | Underperform -> Underperform |
| 2025-01-28 | Citigroup | Maintains | Neutral -> Neutral |
| 2025-01-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-10 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-01-08 | Truist Securities | Maintains | Hold -> Hold |
| 2025-01-02 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-12-10 | B of A Securities | Reiterate | Underperform |
| 2024-11-27 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-11-15 | Wolfe Research | Initiate | Peer Perform |
AMGEN INC / AMGN FAQ
What do analysts expect the price target to be for AMGEN INC (AMGN)?
40 analysts have analysed AMGN and the average price target is 319.63 USD. This implies a price decrease of -0.07% is expected in the next year compared to the current price of 319.86.
How do analysts rate AMGEN INC (AMGN)?
The consensus rating for AMGEN INC (AMGN) is 72 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover AMGEN INC (AMGN) stock?
The number of analysts covering AMGEN INC (AMGN) is 40.